mRNA; however, 10 of 13 M2/M3/M4 samples expressed it. In normal human myeloid cells, Id2 mRNA was expressed in cultured macrophages from bone marrow and in mature granulocytes and monocytes from peripheral blood. The half-life of Id2 mRNA was short (1 hour), and its expression was inducible by cessation of protein synthesis. Id3 mRNA was moderately expressed in monoblastic cell lines (THP-1 and U-937). and levels decreased with their differentiation. Almost no Id3 expression was detectable in either other myeloid leukemia lines, fresh leukemic samples, or normal human myeloid cells by Northern analyses. Id1 mRNA was not detected by polymerase chain reaction in either leukemic or normal myeloid cells except in K562 myeloidlerythroid cells. These results showed that Id2 mRNA was constitutively expressed in more mature myeloid blast cells and level markedly increased with terminal myeloid differentiation, suggesting that Id2 protein may inhibit an HLH transcriptional complex that normally represses myeloid differentiation.
Id2 Expression Increases With Differentiation of Human Myeloid Cells
By Akira Ishiguro, Konstantin S. Spirin NUMBER OF transcriptional factors that play fundamental roles in the control of cellular proliferation and differentiation share a helix-loop-helix (HLH) motif.'.' Most HLH proteins have a basic, DNA binding region that contacts the E-box of target genes to regulate their transcript i~n .~.~ A family of HLH proteins that lacks the basic DNAbinding domain can interfere with transactivation by basic HLH proteins. These dominant negative regulators of transcription are known as Ids (inhibitor of DNA binding or differentiati~n).~ The mammalian Id protein family consists of murine Idl,5 Id2,6 HLH462/Id3,7 and Id48; rat Id1,9 Id2," and Id3"; human Idl,''.'' Id2,I3 and heir-1kILH 1R211 Id3.14,15 Actions of murine Id1 during the differentiation of muscle cells have been well explored. The Id1 forms nonfunctional hetero-oligomers with E2A proteins and inhibits E2A/MyoD complexes from binding to the E-box, thereby preventing transactivation of muscle specific gene^.'.^.'^ Id1 also represses transcriptional activation of the promoters for the genes of Ig K hai in,'^.'^ insulin," pro-opiomelanocortin," and osteocalcin. ' in the presence of Lu-CSFI-conditioned medium. Cell fractions were assessed by cytological examinations of the cytocentrifuge preparations stained with either May-Griinwald-Giemsa or a-naphthyl butyrate (ANB) esterase, by nitroblue tetrazolium (NBT) tests, and by fluorescence-activated cell sorting (FACS) Samples from leukemic patients all had more than 80% of leukemic blasts in MNC populations.
Leukemic cells were cultured in a medium (JRH Biosciences, Lenexa, KS) supplemented with 10% fetal bovine serum (GIBCO, Grand Island, NY) at 37°C under air with 5% CO2. To determine the role of new protein synthesis on regulation of Id mRNA expression, leukemic cells were treated with 20 pglmL CHX, an inhibitor of protein synthesis (protein synthesis inhibited by about 95% as measured by 30 minutes of incubation with l pCi '%methionine after 3 hours of exposure to CHX; data not shown). To examine the stability of Id mRNA, cells were exposed to 6 pg/mL ACTD, an inhibitor of RNA synthesis. All experiments were performed twice to three times, and representative data were shown in each figure. DNA probes. A human Id1 cDNA probe (1.0 kb of Pst I-Xho I cDNA fragment) was made from a plasmid pcD2-IdlH kindly provided by Dr K. Noda (Science University of Tokyo, Noda, Japan)." A human Id2 cDNA fragment (440 bp) was excised with Apa I and Xho I from a plasmid pId2FL.I' A human Id3 cDNA probe (0.9-kb EcoRI-BamHI cDNA fragment) was prepared from a plasmid 1R21." A P-actin probe (0.7-kb EcoRI-BamHI cDNA fragment) was obtained from pHFA-3'ut plasmid." These DNAs were purified as previously reported,' and labeled with 32P using a random priming method."
Isolation of RNA and analysis by Northern blot hybridization. Total RNA was isolated by a hot phenol method" from myeloid leukemia cells and normal bone marrow MNC. Northern blotting and hybridization was performed as previously rep~rted.**~~" Briefly, total RNA was electrophoresed on 1.2% agarose gel containing 660 mmol/L formaldehyde and transferred onto a nylon membrane. The filter was baked, prehybridized at 42°C and hybridized with the labeled cDNA probes at 42°C. The filters were washed to a stringency of 0.1 X SSPE at 65°C and then exposed to a Kodak x-ray film (Eastman Kodak, Rochester, NY) for 16 to 72 hours at -80°C. Blots were sequentially hybridized with labeled DNA for Id2-, Id3-, P-actin-, and Idl-selected blots. Autoradiograms were scanned by a densitometric imaging analyzer to quantify intensities of hybridizing signals. Relative intensities of signals for the Id mRNAs were normalized by the P-actin signals on the same lanes. The density ratio of IdslP-actin signal on the control lane was assigned to be 1 (baseline).
RT-PCR. First-strand cDNA was synthesized from I pg total RNA in 100 p L reaction using a cDNA synthesis kit (GIBCO BRL) including Moloney's murine leukemia virus (MMLV) reverse transcriptase. The cDNA ( 5 pL) was amplified by PCR in a total of 50 p L Taq polymerase buffer (GIBCO BRL) containing 100 pmol/L dNTPs, 1.3 U Taq polymerase (GIBCO BRL), and 250 nmol/L of sense and antisense primers. Human Id1 primers were designed as S'-TTCAGCCAGTCGCCAAGAATC-3' (sense, nt 15 to 35) and S'-GCGCTGATCTCGCCGTTGAG-3' (antisense, nt 426 to 4445.': Human Id3 primers were designed as 5'-AATGGATCCTGCAC-CACGGGAAC-3' (sense. nt 36 to 58) and 5'-GTCAGGACACGG-CCGAGTCAGTGG-3' (antisense, nt 477 to SOO).'" 0-actin primers were S'-CTTCTACAATGAGCTGGGTG-3' (sense, nt 308 to 327) and S'-TCATGAGGTAGTCAGTCAGG-3' (antisense, nt S93 to 612)." The reaction consisted of 25 cycles of denaturation at 94°C for I minute, annealing at 55°C for 1 minute, and extension at 72°C for 1 minute in a Perkin-Elmer DNA thermal cycler (Perkin-Elmer, Norwalk, CT). The PCR products were electrophoresed on 1 % agarose gel and transferred onto the nylon filters. The filters were baked. prehybridized, and hybridized. The filters were washed to a stringency of 0 . 2~ SSC at 57°C and then exposed to the x-ray film. (Fig 2) .
RESULTS
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In contrast to HL-60, PLB-985 myelomonocytic cells constitutively expressed Id2 mRNA (Fig 3) . Stimulation of PLB-985 cells with dibutyryl cAMP produced a transient but reproducible increase in Id2 mRNA levels at 2 hours, with subsequent downregulation (Fig 3A) . More than 80% of the blasts became NBT-positive granulocyte-like cells at 48 hours postinduction. Also, treatment of PLB-985 cells with forskolin slightly enhanced Id2 signals concomitant with their granulocytic differentiation (data not shown). The expression of Id2 mRNA was biphasically upregulated after culture of PLB-985 cells with PMA (Fig 3B) . The first peak of increased expression (IO-fold) occurred at 2 hours and the second peak of enhanced expression (sixfold) was found at 24 hours during their induction of differentiation. More than 90% of the blasts differentiated to ANB-positive rnacrophage-like cells at 48 hours of induction. The Id3 expression in PLB-985 cells increased slightly after 24 hours of exposure to dibutyryl cAMP (Fig 3A) . but expression was not detectable throughout their culture with PMA (Fig 3B) .
The THP-I and U-937 monoblasts constitutively expressed Id2 mRNA; and Id2 mRNA levels were upregulated upon PMA induction of macrophage-like differentiation, with peak levels of expression at 8 hours for THP-I (sevenfold) and at 6 hours for U-937 (sixfold). The Id3 mRNA expression in both THP-I and U-937 cells was rapidly downregulated after exposure to PMA.
Expression qf Id2 mRNA in fresh m.veloid leukemia cells. The expression of Id2 and Id3 mRNAs was analyzed in fresh AML blasts obtained from 22 patients. Figure 4 shows that 13 (Fig SA) . The expression of Id2 mRNA was found in mature granulocytes, monocytes, and lymphocytes isolated from peripheral blood and bone marrow macrophages (Fig SA) . The expression of Id1 and Id3 mRNAs was not detected in these cells by Northern hybridization (Fig SA and data not shown) . However, the RT-PCR analyses did show mRNA expression of Id3, but not Id I , in these mature cells (Fig 5B and C) .
Steady-state Id2 mRNA h a s CI short half-lfe. We examined the stability of Id2 mRNA using AML samples expressing Id2 transcripts. As observed in Fig 6A, exposure of cells from case no. 1 1 (FAB M2) to ACTD reduced the accumulation of Id2 mRNA by 60% at 1 hour and by 80% at 2 hours in comparison to the basal level. The levels of Id2 mRNA in case no. 10 (FAB M2) decreased by 40% at I hour after ACTD treatment (Fig 6B) . The relative intensities of Id2 mRNA signals indicates that the half-life of Id2 mRNA was approximately I hour ( Fig 6D) . Inhibition of protein synthesis incremes rrccrrnlrtlrtion of Id2 rnRNA. Certain RNA species with short half-lives are stabilized with CHX.3h We analyzed how cessation of protein synthesis modulates Id2 mRNA levels in leukemic cells. Exposure of HL-60 cells to CHX increased the accumulation of Id2 mRNA, and coexposure of these cells with both CHX and an inducer of differentiation (either DMSO or PMA) did not superinduce Id2 mRNA expression (Fig 2) . Similarly. expression of Id2 mRNA in U-937 cells was enhanced by CHX treatment and was not superinduced by coculture with CHX and PMA (Fig 7B) . Leukemic cells from case no. 10 (FAB M2) and case no. 8 (FAB M 1) also displayed increased Id2 mRNA expression after exposure to CHX (Fig 6B and  C) .
DISCUSSION
We have examined the expression of Id mRNAs in human myeloid cells using leukemic cell lines, primary AML cells. and normal hematopoietic cells.
We have found that Id2 mRNA was predominantly expressed in myelomonoblastic and monoblastic cells as compared with myeloblastic or megakaryoblastic cells. In addition, we have studied the modulation of expression of Id2 and Id3 transcripts in leuke- 
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--" Our data showed that human Id1 mRNA is undetectable even by RT-PCR in leukemic and normal myeloid cells except in K562 myeloid/erythroid cells. Because murine Id1 has been suggested to inhibit the differentiation of myeloid23 and erythroid further studies will determine the roles of Id1 in human hematopoiesis.
In our studies, Id2 mRNA levels increased when new protein synthesis was inhibited with CHX in the myeloid leukemic cells from both cell lines and patient samples. This enhanced accumulation may be. in part, due to stabilization of Id2 transcripts." The half-life of Id2 mRNA was short ( -l hour) for unstimulated AML cells. This moderately short half-like may allow for rapid modulation of levels of this transcript during cellular proliferation and differentiation.
In The regulation of Ids during hematopoiesis is no less confusing. For example, SCL (m/-/). a basic HLH protein, probably forms stimulatory heterodimers (ral-IE2A) during normal erythroid development.'",J',J' Levels of murine Id1 and human Id2 mRNA decrease during differentiation of murine erythroleukemic cells and human erythroid cells, respectively, as stimulatory levels of SCL d e v e l~p .~~"~'~~~'~" ' The situation with myeloid cells is complicated. A biphasic pattern consisting of a transient decrease followed by an increase of Id 1 mRNA occurred in the 32DC 13 early myeloid cells as they differentiated to granulocytes.'' Furthermore, uncontrolled overexpression of Id1 in these 32DC13 cells inhibited their differentiation. In contrast, another murine myeloid cell line, M l , had an increase of Id I and Id2 mRNA levels as the cells were induced to differentiate to macrophages." Furthermore, the same investigators showed that tu/-/ heterodimerized with a E2A protein (E47) and repressed the ability of E47 to transactivate through the Ebox motif"; moreover, recombinant Id1 or Id1 from cellular lysate of differentiated MI cells inhibited E47-fa/ / binding to the E-box DNA."
We show that, as human myeloid cells differentiate, they accumulate prominent levels of Id2 mRNA. We speculate that a group of basic HLH proteins is functional in immature proliferating myeloid cells and that they perhaps bind to and stimulate transcriptional regulatory sequences of a set of ISHIGURO ET AL genes required for cellular growth and/or suppression of differentiation. The expression of Id2 may foster human myeloid differentiation by inhibiting the repression of differentiation mediated by the HLH proteins. Modulation of Id2 may thus represent an important regulatory process in human myeloid differentiation.
Taken together, the results of expression of Id proteins are probably more complicated than previously appreciated. perhaps inducing differentiation and inhibiting proliferation in cells of certain tissue and blocking differentiation and enhancing proliferation in others. The role of Id proteins in myelopoiesis may require the initial identification of the genes important in myelopoiesis and then a dissection of how Id proteins influence the expression of these key genes.
